HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Massimo Breccia Selected Research

Fibrosis (Cirrhosis)

2/2017How ruxolitinib modified the outcome in myelofibrosis: focus on overall survival, allele burden reduction and fibrosis changes.
11/2014Disappearance of fibrosis in secondary myelofibrosis after ruxolitinib treatment: new endpoint to achieve?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Massimo Breccia Research Topics

Disease

174BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
05/2024 - 04/2004
37Primary Myelofibrosis (Myelosclerosis)
02/2024 - 10/2004
34Myelodysplastic Syndromes (Myelodysplastic Syndrome)
10/2023 - 01/2002
33Neoplasms (Cancer)
03/2024 - 01/2002
30Acute Promyelocytic Leukemia
11/2021 - 02/2002
19Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2022 - 01/2002
16Blast Crisis (Blast Phase)
12/2023 - 04/2004
15Philadelphia Chromosome
01/2023 - 09/2006
13Leukemia
10/2022 - 11/2004
12Anemia
12/2023 - 06/2010
12Infections
01/2023 - 08/2003
11Splenomegaly
02/2023 - 01/2016
9Hematologic Neoplasms (Hematological Malignancy)
02/2023 - 02/2002
8Thrombocytopenia (Thrombopenia)
05/2024 - 02/2018
6Polycythemia Vera
03/2024 - 10/2018
6Residual Neoplasm
02/2023 - 09/2003
6Fatigue
01/2023 - 10/2014
6Pathologic Complete Response
09/2011 - 02/2002
5Hypertension (High Blood Pressure)
01/2023 - 03/2015
5Iron Overload
01/2022 - 07/2013
5Pleural Effusion (Pleural Effusions)
11/2021 - 09/2010
5Thrombosis (Thrombus)
08/2021 - 09/2015
5Chromosome Aberrations (Chromosome Abnormalities)
11/2017 - 01/2009
5Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
04/2013 - 08/2012
4COVID-19
05/2024 - 06/2021
4Cardiovascular Diseases (Cardiovascular Disease)
11/2023 - 05/2008
4Disease Progression
10/2023 - 08/2003
4Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
02/2023 - 10/2008
4Myeloid Leukemia (Leukemia, Myelocytic)
01/2023 - 08/2016
3Essential Thrombocythemia
03/2024 - 10/2018
3Hemorrhage
10/2023 - 03/2009
3Cytopenia
01/2023 - 08/2012
3Melanoma (Melanoma, Malignant)
01/2023 - 01/2021
3Skin Neoplasms (Skin Cancer)
01/2023 - 01/2021
3Thrombocytosis (Thrombocythemia)
01/2023 - 01/2008
3Exanthema (Rash)
10/2014 - 05/2011
2Leukocytosis (Pleocytosis)
02/2023 - 12/2002
2Hematologic Diseases (Blood Diseases)
01/2023 - 12/2019
2Chronic Disease (Chronic Diseases)
06/2022 - 02/2015
2Sepsis (Septicemia)
05/2022 - 11/2015
2Venous Thromboembolism
01/2021 - 10/2020
2Atrial Fibrillation
12/2020 - 10/2020
2Frailty
11/2020 - 05/2018
2Obesity
01/2020 - 03/2015
2Pancreatitis
12/2019 - 12/2009
2Multiple Myeloma
12/2019 - 04/2012
2Genetic Translocation (Chromosomal Translocation)
01/2018 - 01/2015
2Fibrosis (Cirrhosis)
02/2017 - 11/2014
2Type 2 Diabetes Mellitus (MODY)
07/2015 - 04/2012
2Non-Hodgkin Lymphoma (Lymphosarcoma)
10/2011 - 02/2008
2Myeloproliferative Disorders (Myeloproliferative Disorder)
07/2009 - 11/2005
1Inflammation (Inflammations)
02/2024

Drug/Important Bio-Agent (IBA)

94Imatinib Mesylate (Gleevec)FDA Link
09/2023 - 04/2004
86Tyrosine Kinase InhibitorsIBA
05/2024 - 12/2008
41ruxolitinibIBA
02/2024 - 11/2014
28nilotinibFDA Link
11/2023 - 01/2007
25Dasatinib (BMS 354825)FDA Link
01/2023 - 01/2007
20Tretinoin (Retinoic Acid)FDA LinkGeneric
11/2021 - 02/2002
16Azacitidine (5 Azacytidine)FDA Link
10/2020 - 10/2011
15ponatinibIBA
11/2023 - 01/2016
12Arsenic Trioxide (Trisenox)FDA Link
11/2021 - 05/2004
10DeferasiroxFDA Link
01/2022 - 09/2012
10Phosphotransferases (Kinase)IBA
12/2020 - 10/2008
8Lenalidomide (CC 5013)FDA Link
01/2022 - 09/2010
7asciminibIBA
05/2024 - 12/2019
6InterferonsIBA
03/2024 - 01/2011
6Hemoglobins (Hemoglobin)IBA
12/2023 - 03/2015
6IronIBA
01/2017 - 09/2012
5Hydroxyurea (Hydrea)FDA LinkGeneric
07/2023 - 01/2012
5AnticoagulantsIBA
01/2021 - 11/2005
5Interferon-alpha (Interferon Alfa)IBA
01/2016 - 02/2008
4bosutinibIBA
08/2021 - 01/2015
4ErythropoietinFDA Link
09/2020 - 08/2014
4AnthracyclinesIBA
12/2019 - 02/2011
4Gemtuzumab (Mylotarg)FDA Link
02/2011 - 10/2004
3Lipase (Acid Lipase)FDA Link
05/2024 - 12/2009
3amsonic acid (DAS)IBA
11/2021 - 01/2016
3Ferritins (Ferritin)IBA
08/2020 - 07/2013
3Glucose (Dextrose)FDA LinkGeneric
11/2012 - 05/2010
2Biomarkers (Surrogate Marker)IBA
02/2024 - 02/2009
2VaccinesIBA
02/2023 - 09/2021
2EnzymesIBA
01/2023 - 07/2009
2LDL Lipoproteins (beta Lipoproteins)IBA
08/2021 - 01/2020
2Therapeutic UsesIBA
01/2021 - 04/2018
2CytokinesIBA
10/2020 - 02/2002
2Chelating AgentsIBA
07/2015 - 07/2013
2NF-kappa B (NF-kB)IBA
07/2013 - 04/2011
2Amphotericin B (Amphotericin)FDA LinkGeneric
04/2012 - 04/2004
2Bortezomib (Velcade)FDA Link
04/2012 - 04/2011
2Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric
10/2010 - 12/2008
1Interferon alpha-2 (Roferon-A)FDA Link
03/2024

Therapy/Procedure

92Therapeutics
03/2024 - 01/2002
22Drug Therapy (Chemotherapy)
10/2022 - 02/2002
5Stem Cell Transplantation
10/2022 - 03/2003
4Salvage Therapy
01/2020 - 11/2010
3Chelation Therapy (Therapy, Chelation)
10/2015 - 09/2012
2Polypharmacy
11/2020 - 11/2016
2Homologous Transplantation
01/2020 - 01/2010
2Duration of Therapy
04/2013 - 05/2009
2Palliative Care (Palliative Therapy)
03/2009 - 05/2007